286 related articles for article (PubMed ID: 21467250)
1. Hepatic perfusion disorder associated with focal liver lesions: contrast-enhanced US patterns--correlation study with contrast-enhanced CT.
Zhou X; Luo Y; Peng YL; Cai W; Lu Q; Lin L; Sha XX; Li YZ; Zhu M
Radiology; 2011 Jul; 260(1):274-81. PubMed ID: 21467250
[TBL] [Abstract][Full Text] [Related]
2. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
[TBL] [Abstract][Full Text] [Related]
3. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
Burns PN; Wilson SR
Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
[TBL] [Abstract][Full Text] [Related]
4. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
6. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
[TBL] [Abstract][Full Text] [Related]
7. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors.
Wan CF; Du J; Fang H; Li FH; Zhu JS; Liu Q
Radiology; 2012 Feb; 262(2):450-9. PubMed ID: 22282183
[TBL] [Abstract][Full Text] [Related]
8. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
Parikh T; Drew SJ; Lee VS; Wong S; Hecht EM; Babb JS; Taouli B
Radiology; 2008 Mar; 246(3):812-22. PubMed ID: 18223123
[TBL] [Abstract][Full Text] [Related]
9. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound versus computed tomographic angiography for surveillance of endovascular abdominal aortic aneurysm repair.
Ten Bosch JA; Rouwet EV; Peters CT; Jansen L; Verhagen HJ; Prins MH; Teijink JA
J Vasc Interv Radiol; 2010 May; 21(5):638-43. PubMed ID: 20363153
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
Clevert DA; Jung EM; Stock KF; Weckbach S; Feuerbach S; Reiser M; Jung F
Z Gastroenterol; 2009 Dec; 47(12):1195-202. PubMed ID: 19960397
[TBL] [Abstract][Full Text] [Related]
12. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
13. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT.
Luo W; Numata K; Morimoto M; Kondo M; Takebayashi S; Okada M; Morita S; Tanaka K
Radiology; 2009 Apr; 251(1):287-95. PubMed ID: 19221060
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
[TBL] [Abstract][Full Text] [Related]
15. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
Braga HJ; Choti MA; Lee VS; Paulson EK; Siegelman ES; Bluemke DA
Radiology; 2002 May; 223(2):525-31. PubMed ID: 11997563
[TBL] [Abstract][Full Text] [Related]
16. Obstruction at middle hepatic venous tributaries in modified right lobe grafts after living-donor liver Transplantation: diagnosis with contrast-enhanced US.
Park YS; Kim KW; Kim SY; Lee SJ; Lee J; Kim JH; Lee JS; Kim HJ; Song GW; Hwang S; Lee SG
Radiology; 2012 Nov; 265(2):617-26. PubMed ID: 22923713
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
18. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
[TBL] [Abstract][Full Text] [Related]
20. Characterization of focal liver lesions by means of assessment of hepatic transit time with contrast-enhanced US.
Zhou X; Liu JB; Luo Y; Yan F; Peng Y; Lin L; Zhuang H
Radiology; 2010 Aug; 256(2):648-55. PubMed ID: 20656845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]